Anna Kettermann

2.1k total citations
27 papers, 1.4k citations indexed

About

Anna Kettermann is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Anna Kettermann has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Anna Kettermann's work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (17 papers) and Hormonal and reproductive studies (4 papers). Anna Kettermann is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (17 papers) and Hormonal and reproductive studies (4 papers). Anna Kettermann collaborates with scholars based in United States. Anna Kettermann's co-authors include E. Jeffrey Metter, Patricia Landis, Jonathan I. Epstein, Luigi Ferrucci, Patrick C. Walsh, Stacy Loeb, H. Ballentine Carter, Bruce J. Trock, H. Ballentine Carter and Christopher A. Warlick and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Journal of Urology.

In The Last Decade

Anna Kettermann

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kettermann United States 15 1.1k 343 183 179 125 27 1.4k
Larry Goldenberg Canada 21 770 0.7× 249 0.7× 159 0.9× 184 1.0× 150 1.2× 64 1.5k
Peter Ka‐Fung Chiu Hong Kong 20 795 0.7× 262 0.8× 180 1.0× 189 1.1× 210 1.7× 135 1.4k
Benjamin J. Davies United States 17 477 0.4× 485 1.4× 190 1.0× 181 1.0× 183 1.5× 64 1.1k
Hyeon Jeong South Korea 22 817 0.7× 252 0.7× 235 1.3× 165 0.9× 292 2.3× 99 1.4k
Libni Eapen Canada 24 809 0.7× 703 2.0× 60 0.3× 384 2.1× 149 1.2× 72 1.8k
S. BRATELL Sweden 9 1.7k 1.6× 497 1.4× 266 1.5× 458 2.6× 111 0.9× 10 2.1k
Ronald Kodama Canada 14 661 0.6× 279 0.8× 154 0.8× 189 1.1× 150 1.2× 37 1.1k
Allyn W. Kimball United States 14 732 0.7× 209 0.6× 259 1.4× 92 0.5× 46 0.4× 23 1.3k
Greg Shaw United Kingdom 24 742 0.7× 209 0.6× 170 0.9× 186 1.0× 139 1.1× 76 1.3k
Robert W. Galbreath United States 33 3.1k 2.8× 643 1.9× 490 2.7× 195 1.1× 600 4.8× 138 3.5k

Countries citing papers authored by Anna Kettermann

Since Specialization
Citations

This map shows the geographic impact of Anna Kettermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kettermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kettermann more than expected).

Fields of papers citing papers by Anna Kettermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kettermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kettermann. The network helps show where Anna Kettermann may publish in the future.

Co-authorship network of co-authors of Anna Kettermann

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kettermann. A scholar is included among the top collaborators of Anna Kettermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kettermann. Anna Kettermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Yoonhee, et al.. (2023). Statistical methods for handling missing data to align with treatment policy strategy. Pharmaceutical Statistics. 22(4). 650–670. 13 indexed citations
2.
Kettermann, Anna, et al.. (2022). Informatics in Medical Product Regulation: The Right Drug at the Right Dose for the Right Patient. Methods in molecular biology. 2486. 277–314. 1 indexed citations
3.
Di, Junrui, Charmaine Demanuele, Anna Kettermann, et al.. (2021). Considerations to address missing data when deriving clinical trial endpoints from digital health technologies. Contemporary Clinical Trials. 113. 106661–106661. 29 indexed citations
4.
Kasza, Karin A., Maansi Bansal‐Travers, Richard J. O’Connor, et al.. (2013). Cigarette Smokers’ Use of Unconventional Tobacco Products and Associations With Quitting Activity: Findings From the ITC-4 U.S. Cohort. Nicotine & Tobacco Research. 16(6). 672–681. 49 indexed citations
5.
Loeb, Stacy, H. Ballentine Carter, Edward M. Schaeffer, et al.. (2011). Distribution of PSA Velocity by Total PSA Levels: Data From the Baltimore Longitudinal Study of Aging. Urology. 77(1). 143–147. 10 indexed citations
6.
Ross, Ashley E., Stacy Loeb, Patricia Landis, et al.. (2010). Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program. Journal of Clinical Oncology. 28(17). 2810–2816. 201 indexed citations
7.
Kettermann, Anna, Luigi Ferrucci, Bruce J. Trock, et al.. (2010). Interpretation of the prostate‐specific antigen history in assessing life‐threatening prostate cancer. British Journal of Urology. 106(9). 1284–1292. 8 indexed citations
8.
Pierorazio, Phillip M., et al.. (2009). Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging. British Journal of Urology. 105(6). 824–829. 72 indexed citations
9.
Loeb, Stacy, H. Ballentine Carter, Edward M. Schaeffer, et al.. (2009). Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging. The Journal of Urology. 182(6). 2646–2652. 21 indexed citations
10.
Loeb, Stacy, H. Ballentine Carter, Patrick C. Walsh, et al.. (2009). Single Nucleotide Polymorphisms and the Likelihood of Prostate Cancer at a Given Prostate Specific Antigen Level. The Journal of Urology. 182(1). 101–105. 20 indexed citations
11.
Loeb, Stacy, et al.. (2009). Prostate Volume Changes Over Time: Results From the Baltimore Longitudinal Study of Aging. The Journal of Urology. 182(4). 1458–1462. 90 indexed citations
12.
Loeb, Stacy, et al.. (2008). PSA Doubling Time Versus PSA Velocity to Predict High-Risk Prostate Cancer: Data from the Baltimore Longitudinal Study of Aging. European Urology. 54(5). 1073–1080. 34 indexed citations
13.
14.
Kettermann, Anna, et al.. (2008). PROSTATE SPECIFIC ANTIGEN TESTING AMONG THE ELDERLY: WHEN TO STOP?. The Journal of Urology. 179(4S). 600–600. 8 indexed citations
15.
Pierorazio, Phillip M., et al.. (2008). SERUM TESTOSTERONE IS ASSOCIATED WITH AGGRESSIVE PROSTATE CANCER: RESULTS FROM THE BALTIMORE LONGITUDINAL STUDY OF AGING. The Journal of Urology. 179(4S). 150–150. 1 indexed citations
16.
Carter, H. Ballentine, Anna Kettermann, Luigi Ferrucci, Patricia Landis, & E. Jeffrey Metter. (2007). Prostate-Specific Antigen Velocity Risk Count Assessment: A New Concept for Detection of Life-Threatening Prostate Cancer During Window of Curability. Urology. 70(4). 685–690. 38 indexed citations
17.
Carter, HB, Anna Kettermann, Christopher A. Warlick, et al.. (2007). Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. International braz j urol. 33(6). 50 indexed citations
18.
Ferrucci, Luigi, Anna Kettermann, Jonathan L. Wright, et al.. (2007). Response: Re: Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of Curability. JNCI Journal of the National Cancer Institute. 99(6). 490–490. 1 indexed citations
19.
Kettermann, Anna, et al.. (2007). 1743: Risk Count Assessment: A New Concept for Detection of Life Threatening Prostate Cancer During a Window of Curability. The Journal of Urology. 177(4S). 579–580. 3 indexed citations
20.
Carter, H. Ballentine, Luigi Ferrucci, Anna Kettermann, et al.. (2006). Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of Curability. JNCI Journal of the National Cancer Institute. 98(21). 1521–1527. 325 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larry Goldenberg Breakdown of academic impact, for papers by Peter Ka‐Fung Chiu Breakdown of academic impact, for papers by Benjamin J. Davies Breakdown of academic impact, for papers by Hyeon Jeong Breakdown of academic impact, for papers by Libni Eapen Breakdown of academic impact, for papers by S. BRATELL Breakdown of academic impact, for papers by Ronald Kodama Breakdown of academic impact, for papers by Allyn W. Kimball Breakdown of academic impact, for papers by Greg Shaw Breakdown of academic impact, for papers by Robert W. Galbreath
Rankless by CCL
2026